Openseed
OpenseedVC focuses on investing first checks into experienced operators building companies at day zero, often before institutional capital shows up. The firm believes that early-stage failure is often related to team vision and execution under uncertainty, rather than just the idea itself. They aim to be the partner who leads with conviction on day zero, providing support even before traditional VCs arrive. OpenseedVC aims to invest in the next generation of world-changing technology solutions, built by exceptional operators who have the grit to navigate uncertainty in complex, emerging market environments. Maria Rotilu, Founder & General Partner, brings a background of scaling products and teams at Uber and Branch in complex, emerging market environments and also led the Oxford Seed Fund and co-led Octopus Ventures’ £10m First Cheque Fund for Europe. This experience has shaped her conviction that early-stage failure is often not about the idea; it is about team vision and execution under uncertainty. Openseed invests in outlier tech operators with unusually fast execution speed, obsessed domain experts with a bias for action, and serial founders with a track record of starting and scaling startups and innovations. The fund emphasizes providing conviction and support during the fragile early stages of execution, when even small, "day zero" decisions can compound into either massive scale or structural failure. OpenseedVC's operator network provides support from seasoned operators across Software Engineering, Product, People, and Go-To-Market.
OpenseedVC
Openseed VC invests in exceptional operators who are starting their own companies, providing up to $150k in seed funding and leveraging a global operator network for support from zero to one. Focuses on reinventing enterprise-scale rails for modern businesses, health innovations, and work productivity.
Openspace Ventures
Openspace Ventures is a multi-strategy asset manager focused on Southeast Asia, investing in tech-native and tech-enabled companies across multiple stages and product needs. With US$800M in committed capital across 6 funds, the firm targets early and growth-stage companies within various sectors. They emphasize using 'Active Intelligence' to work with portfolio companies, aiming to help them realize bolder visions and accelerate progress responsibly and viably. The firm's investment approach is driven by a deep understanding of the Southeast Asian market, leveraging a diverse team with varied experiences and an always-available operational team. They focus on bridging the climate funding gap in the region, actively investing in the emerging climate tech opportunity. Openspace combines a strong local presence, market understanding, and ecosystem partnerships to deliver value in this sector. They also have a focus on diversity within their own team and encourage work-life flexibility. Openspace aims to transform categories, lives, and culture through their investments. They partner with companies and offer expertise and experiences to help them grow from strength to strength. The firm states that they are always there to help their companies when and where they ask for it and partner with candour and good humour. They are also active in producing research and reports. The Coalesce Index, for example, measures the interconnectedness of Southeast Asia and provides key learnings for investors, founders, and observers in the region.
Opera Tech Ventures
Opera Tech Ventures, launched in Paris in 2018, is the venture capital arm of BNP Paribas Group, dedicated to supporting the global transformation of the financial industry. They aim to foster the emergence of future category leaders by providing financial resources, domain expertise, industry connections, and influence. The firm operates within the financial system, leveraging its position to offer unique access to resources, maximizing the chances for portfolio companies to thrive faster. Their investment approach is pragmatic, opportunistic, and evergreen, designed to support entrepreneurs throughout their entire journey, from early stage to scale. Opera Tech Ventures looks for visionary innovation, backing bold entrepreneurs nurturing new visions of the future. They also prioritize execution-driven teams, supporting exceptional, mission-driven individuals able to deliver under demanding conditions. Finally, they value tech builders who shape long-lasting moats and deliver outstanding value. Opera Tech Ventures focuses on investing in disruptors of the financial industry, encompassing fintech, insurtech, and related areas. They have a global reach, supporting transformative businesses in Europe, the Americas, and Asia.
Orange Ventures
Orange Ventures operates with the aim of creating value for both their portfolio companies and Orange. It combines the independence and quick decision-making of traditional VCs with the technological and commercial expertise of the Orange Group. They have streamlined their governance to facilitate swift investments and refined their value-unlocking process for startups by leveraging Orange's ecosystems. They share resources and expertise, providing support, collaboration, and access to the Orange Group's resources. A dedicated team works with each portfolio company post-investment, and the entire management company is committed to adding value by utilizing Orange's vast ecosystems, technical expertise, and customer reach to help startups achieve their goals.
Oras Invest
Oras Invest is a Finnish family-owned investment company focused on long-term industrial ownership. Their strategy centers around developing companies within building, water, and bio-based materials value chains, as well as closely related sectors. They distinguish themselves from financial investors through an exceptionally long ownership horizon, spanning generations and decades, allowing for patient development and growth of their portfolio companies. With roots in family entrepreneurship, stemming from the faucet company Oras founded in 1945, they possess unique industrial expertise within their network. Their approach involves active board work and close cooperation with the management and other significant owners of their portfolio companies. This hands-on involvement aims to capitalize on the strengths and potential of each company, fostering sustainable growth and value creation. The firm's investment philosophy is anchored in a deep understanding of industrial businesses and a commitment to long-term value creation, rather than short-term financial gains. Oras Invest's current industrial ownerships include prominent companies such as Oras Group, Kemira, Valmet, Georg Fischer, Lindab, and Konecranes, demonstrating their focus on established, market-leading businesses. The net asset value of Oras Invest was EUR 1.7 billion at the end of 2024. Their investment strategy is clearly focused on established industrial players where they can exert influence through significant ownership stakes. They appear to favor companies with a strong market position, global reach, and a focus on sustainable solutions. The inclusion of companies like Kemira (sustainable chemical solutions), Valmet (pulp, paper, and energy industries), and Lindab (energy-efficient ventilation) suggests an interest in environmentally conscious and resource-efficient businesses. The firm’s commitment is reflected in their annual reviews which give insight into the development of their NAV and ownerships.
Orbimed Advisors
OrbiMed is a global investment firm focused on the healthcare industry. They aim to invest in world-class healthcare companies to drive innovation, address unmet medical needs, and improve patient outcomes. They focus on long-term growth trends led by global demographics and scientific innovation in treating disease. OrbiMed believes the healthcare industry's powerful growth profile, coupled with its magnitude and complexity, creates numerous investment opportunities. Their investment strategy is broad and flexible, covering the global healthcare industry from seed-stage venture capital to large publicly-traded companies. They invest through public equity, private equity, and private credit/royalty strategies. In private equity, OrbiMed often acts as a lead investor, actively helping portfolio companies to become market leaders, with a global investment scope including North America, Asia, and Europe. They also offer non-dilutive structured debt capital and royalty monetization solutions to commercial-stage healthcare companies and intellectual property owners. OrbiMed invests in companies engaged in the discovery and development of biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare information technology and services. They seek companies focused on responsible, sustainable growth to build long-term shareholder value. They have been investing globally for over 25 years and currently manage approximately $20 billion across public and private company investments worldwide.
Orbit Capital
Orbit Capital is a venture capital firm focused on growing innovative scale-ups. Their investment strategy centers around championing tech and tech-enabled SMEs and Small Mid Caps into lasting enterprises. They aim to be trusted, value-adding partners to ambitious entrepreneurs, offering experience, ambition, and rigor to support their portfolio companies' growth. The firm seeks companies that have demonstrated resilience in their home market, boast a recurring or strong customer base, and exhibit healthy margins based on global benchmarks, coupled with strong unit economics. They prioritize companies with a minimum run rate of EUR 8M and a growth rate of at least 30% per annum. Orbit Capital's approach appears to be hands-on, emphasizing partnership and value addition. They aim to build a portfolio of champion companies, reflecting a long-term commitment to fostering sustainable growth and positive outcomes for both the companies they invest in and their own stakeholders. The firm values meritocracy, curiosity, commitment, and respect. They are always rising aspirations, fostering a "positive sum" principle, building to last, caring, and radically honest.
Orion Infrastructure Capital (OIC)
Orion Infrastructure Capital (OIC) invests in environmentally and socially innovative infrastructure companies. The firm believes that infrastructure must evolve to address the challenges of generating power, sustaining agriculture, and managing waste, and sees significant opportunity in companies driving this transition. OIC focuses on building collaborative investment partnerships with private businesses, particularly middle market companies and entrepreneurs, that are developing and scaling critical infrastructure solutions. Their goal is to generate strong financial returns for their investors while also creating beneficial outcomes for society, emphasizing responsible investment principles that integrate value creation, risk mitigation, and profitability. OIC aims to bridge the gap between current infrastructure and the infrastructure of tomorrow by providing creative credit, equity, and growth capital solutions. They position themselves as more than just a source of capital, actively collaborating with their partner companies to transform ideas into action and drive long-term value. The firm prioritizes partnerships with companies that can catalyze positive change across infrastructure, energy, and industrial ecosystems, acting as relentless problem solvers to identify and capitalize on opportunities that others may overlook. Their investment approach is driven by a clear-eyed pragmatism coupled with visionary portfolio optimization practices. They emphasize environmental innovation and responsible investment, believing that these principles lead to value creation and maximum profitability. OIC's strategy involves partnering with midsized private companies and family-owned businesses to support the deployment of sustainable infrastructure and technologies, positioning themselves as collaborative partners committed to the long-term success of their portfolio companies and the advancement of a sustainable future.
Orkila Capital
Orkila Capital was formed in 2013 to pursue proprietary and compelling growth equity investment opportunities in the media, entertainment and consumer sectors. With over 20 years of experience, the principals of Orkila seek to leverage their deep industry knowledge and relationships to focus on growth platforms with differentiated brands, IP, assets or content. They aim to invest in the future of iconic brands.
Osney Capital
Osney Capital is a sector specialist venture capital firm focused exclusively on early-stage cybersecurity companies in the UK. Their core strategy revolves around identifying and supporting UK cyber founders during the critical early phases of their growth. They aim to add unique value by leveraging their deep sector expertise and network, focusing their investments where they believe their team can significantly impact the company's success. They aim to specialize in early-stage ventures, providing the resources and knowledge needed to scale effectively. Osney Capital aims to create a supportive environment for its portfolio companies by combining financial investment with strategic guidance and operational support. Their value proposition extends beyond just capital; they strive to be a trusted partner, navigating the complexities of the cybersecurity market with their portfolio companies. The firm appears to have cultivated strong relationships with innovation leaders within the UK cyber ecosystem, working with entities such as NSSIF, Cyber Runway by Plexal, HMGCC CoCreation, UKC3, and Cyber ASAP. Osney Capital also demonstrates a commitment to diversity and inclusion through its participation in the Investing in Women Code. By supporting female entrepreneurship in the UK, the firm aims to contribute to a more diverse and inclusive business ecosystem, recognizing the value it brings to customers, entrepreneurs, businesses, investors, and society. This commitment aligns with the firm's broader objective of fostering innovation and growth within the UK cybersecurity sector. Osney Capital appears to be an active player in the venture capital landscape, offering a Venture Capital Internship Program to cultivate talent and provide opportunities for individuals from non-VC backgrounds to gain hands-on experience. This initiative reinforces their commitment to supporting the wider venture capital community and fostering the next generation of investors.
Ouest Croissance
Ouest Croissance focuses on supporting the development and transmission of SMEs and mid-sized companies (ETI) within the real economy, particularly in regional territories. Their approach involves financial investment and active support at key stages of the company's lifecycle, from growth and transformation to succession planning. They aim to multiply performance by understanding the specific challenges and opportunities of each company and sector. A core component of their investment strategy is incorporating ESG (Environment, Social, and Governance) considerations into their investment decisions and support of portfolio companies.
Outset Ventures
Outset Ventures is a deep technology venture fund and incubator based in Aotearoa New Zealand. They aim to build world-class companies from the lab bench to global scale by providing specialised laboratory space, venture capital, and a curated community of founders. They see New Zealand as a place capable of producing frontier deep tech companies, as evidenced by their history with Rocket Lab. Their new fund, Momentum Fund, will back New Zealand's breakout deep tech winners as they scale globally. They are engaging with institutional and family office investors for this fund.
Owl Ventures
Owl Ventures is a global venture capital firm focused on investing in transformative learning and workforce AI companies across all stages and sectors. The firm believes education is the most powerful driver of human potential and aims to scale the world's most impactful education companies. They have a decade-long focus on EdTech and aim to not just invest but to build the market, scaling companies from pre-revenue to nine-figure businesses and coordinating M&A across their portfolio. Owl Ventures also prioritizes investments that create lasting change by expanding opportunity, driving equity, and advancing lifelong learning. The firm operates as a full-lifecycle partner, leading rounds from pre-seed through IPO and actively engaging throughout the growth cycle. They leverage their global LP network to gain access to global growth opportunities in education, workforce, and AI-driven learning, with investments spanning six continents. Their extensive portfolio of over 100 companies creates powerful synergies in distribution, talent, M&A, and insights, resulting in a network effect that benefits their portfolio companies. Owl Ventures is focused on backing bold ideas in education and work globally. They invest in companies at every stage, from pre-seed to pre-IPO, to help scale companies from their first customers to becoming global category leaders. Their portfolio spans the full learning journey, from PreK-12 and higher education to workforce development and lifelong learning, with a particular emphasis on AI-powered solutions that are reshaping how knowledge is created, shared, and scaled.
Oxford Capital
Oxford Capital is a venture capital firm based in Oxford, UK, that invests in early-stage and growth-stage companies across the UK. They focus on backing founders of innovative companies with disruptive potential, investing from pre-seed to growth and beyond. With over 25 years of experience, they have invested over £500m into over 100 companies. The firm provides individuals, families, and institutions the ability to participate in these investment opportunities. Oxford Capital aims to bridge the gap between entrepreneurs and private capital investors. The firm's strategy involves supporting companies from their earliest stages to later growth, enabling entrepreneurial successes. They are particularly interested in companies leveraging technology and science to solve complex problems. The firm's investment approach emphasizes backing companies that are creating new markets or disrupting existing ones. Oxford Capital looks for founders with a clear vision, strong execution capabilities, and the potential to build large, scalable businesses. They also focus on providing value beyond capital, offering support in areas such as strategy, operations, and fundraising. Oxford Capital actively monitors the venture capital landscape, providing commentary on industry trends and investment policy through its news and views section. They support the Enterprise Investment Scheme (EIS) as a means to encourage investment in early-stage companies. The firm has a strong emphasis on governance and sustainability in both mature and high-growth companies.
Oxford Technology
Oxford Technology specializes in investing in startup and early-stage technology companies based in and around Oxford, UK. Their investment strategy centers around leveraging SEIS and EIS tax reliefs to provide seed and follow-on funding to innovative tech ventures. They manage two funds: a flagship three-year combined SEIS and EIS fund and a Knowledge-Intensive EIS fund, each with slightly different risk/return profiles. The SEIS fund targets earlier-stage companies, investing a portion of the capital upfront and following on with high performers in subsequent years. The Knowledge-Intensive EIS fund focuses on companies already in their portfolio, offering a potentially lower risk/return profile. The firm typically invests up to £150k of seed funding into SEIS-eligible companies and up to £300k of EIS follow-on funding. They emphasize the importance of follow-on investments for achieving the best returns and exit multiples. Oxford Technology also runs WOTAN (Wider Oxford Technology Angel Network) to provide further investment opportunities. The firm prioritizes investments in companies with novel science or technology that can disrupt existing sectors or create new ones. They seek companies that are SEIS-eligible, especially those located in or around Oxford. Oxford Technology's investment approach includes tax relief benefits for investors under SEIS and EIS schemes. They provide investors with opportunities to participate in monthly presentations of follow-on EIS-eligible pitches. They also actively assist portfolio companies in their early years, especially those located near Oxford. Their investment philosophy is oriented towards providing both capital growth and tax reliefs.
Oxford Technology Management
Oxford Technology Management specializes in investing in startup and early-stage technology companies based in and around Oxford since 1983. The firm leverages the UK's SEIS (Seed Enterprise Investment Scheme) and EIS (Enterprise Investment Scheme) tax reliefs to provide investors with tax-efficient access to innovative technology startups. Their investment strategy focuses on providing seed funding to SEIS-eligible companies and follow-on EIS funding to high-performing ventures within their portfolio. The firm believes that the ability to make follow-on investments is crucial for achieving the best returns and highest exit multiples. Oxford Technology manages two funds: a flagship three-year combined SEIS and EIS fund, and an approved Knowledge-Intensive EIS fund. The SEIS and EIS Start-Up Fund invests in approximately eight tech startups over three tax years, allocating a third of the subscription to SEIS companies in the first year and providing follow-on EIS funding in subsequent years. The Knowledge-Intensive EIS Fund invests in five select EIS companies already within the Oxford Technology portfolio, offering a slightly lower risk/return profile due to the companies' progression and higher valuations. The firm emphasizes the benefits of capital growth and tax reliefs associated with SEIS and EIS investments, including income tax reduction, capital gains relief, and tax-free capital gains after three years. Oxford Technology aims to provide investors with opportunities for significant capital growth while mitigating risk through tax advantages and downside protection offered by the schemes. Oxford Technology also operates WOTAN – Wider Oxford Technology Angel Network, connecting investors with early-stage technology opportunities. They host monthly investor presentations featuring follow-on EIS-eligible pitches, further facilitating investment in promising startups.
Oxford University Innovation
Oxford University Innovation (OUI) is the technology transfer and consulting arm of the University of Oxford, acting as a bridge between academic research and commercial application. OUI supports University researchers in commercializing their intellectual property through licensing and spin-out formation. They also facilitate academic consultancy services, connecting external organizations with Oxford's expertise. Their Venture Support & Funding team assists investors and donors interested in early-stage ventures, while the Spinout Equity Management team manages the University's investments in past spinouts. Additionally, OUI supports entrepreneur-driven ventures not directly spun out from the University through their Startup Incubator. OUI plays a crucial role in translating academic knowledge into tangible benefits for society and the economy. OUI operates by identifying promising research outputs from the University of Oxford and facilitating their commercialization. This involves assessing the potential for intellectual property protection, marketing technologies to potential licensees, and assisting with the formation of spin-out companies. They also provide a platform for University staff to offer consultancy services to external organizations, allowing them to apply their expertise to real-world challenges. They work to connect researchers with technology seekers, investors, and other external parties, providing support and advice throughout the process. Their strategy also extends to supporting social ventures, balancing profitability with a mission to deliver positive social, environmental, or cultural change. They are involved with ImpactU, a collective of UK universities supporting mission-driven businesses emerging from academic ecosystems, and actively seek investment from impact investors for research-backed social ventures. The Oxford Innovation Society also serves as a leading forum for collaboration, bringing together researchers and inventors, Oxford spinouts, technology transfer professionals, OUI colleagues, local and national companies, venture capital groups and some of the world’s most innovative minds. OUI operates as a wholly-owned subsidiary of the University of Oxford, overseen by a board of directors with experience from both the University and the broader industry. This structure allows them to leverage the University's research capabilities while maintaining a commercially focused approach. Their overall goal is to maximize the impact of Oxford's research by translating it into products, services, and companies that benefit society.
PFM Health Sciences
PFM Health Sciences, founded in 2004, operates as a healthcare investment advisor managing both public and private investments. The firm is led by Founding Partner and CIO, Brian Grossman. Their investment thesis centers on a powerful, secular healthcare innovation cycle presenting transformative investment opportunities. They believe a specialist, bottom-up, fundamental approach is well-suited to the healthcare sector, capitalizing on secular growth, domain expertise, and demographic trends. PFM Health Sciences emphasizes partnering with companies that demonstrate a measurable and sustainable impact on health outcomes, alongside responsible stewardship of institutional capital. Their approach to risk management and portfolio construction aims to dampen volatility while providing an attractive return/risk profile. A core tenet is the flexibility to invest across the capital structure, engaging with both public and private companies to maximize opportunity. In essence, PFM Health Sciences focuses on identifying and investing in innovative healthcare companies that contribute to positive health outcomes and demonstrate responsible capital management. They leverage a specialized, fundamental approach to navigate the complexities of the healthcare sector, employing a flexible investment strategy that spans public and private markets.
PFR Ventures
PFR Ventures is the largest Fund of Funds manager in Central and Eastern Europe, focused on supporting the development of the domestic Venture Capital and Private Equity market. They invest in VC funds that, in turn, invest in innovative companies. Their strategy involves allocating capital to various VC funds, including those specializing in deep tech, and participating in initiatives like Innovate Poland to further stimulate investment in Polish companies. The firm aims to catalyze the growth of the Polish innovation ecosystem by providing capital and expertise to promising ventures through fund investments.
PGGM
PGGM is a cooperative pension execution organization operating without a profit motive. Their primary mission is to ensure good, affordable, and sustainable pensions for their clients, which are pension funds and their participants. They manage and administer pensions for 5.6 million participants associated with various pension funds, including Pensioenfonds Zorg en Welzijn, Pensioenfonds Metaal en Techniek, Stipp, Bpf Schilders, and Bpf Koopvaardij. PGGM acts as a cooperative pension investor in the Netherlands, offering fiduciary management and asset management services to support pension funds. They emphasize a collaborative approach to pension management, believing in sharing costs and risks to achieve the best outcomes for everyone involved. They aim to have a positive impact on society and the environment through their activities. PGGM is focused on generating returns and managing risk for their pension fund clients. They invest in a range of asset classes, including infrastructure and alternative investments to promote long-term sustainable growth. They publish expert opinions and annual reports to provide transparency and insights into their operations and investment strategies.
PIMCO
PIMCO is a global leader in active fixed income management with expertise in public and private markets. They leverage their global presence, extensive resources, and a proven investment process to help clients achieve long-term goals. Their investment process is refined over 50 years and aims to deliver outperformance across market cycles. They emphasize flexibility, adapting to complex markets, and focus on delivering value to clients through tailored investment solutions and deep market insights. PIMCO actively manages fixed-income securities, adapting to market conditions and aiming to provide attractive returns. Their investment strategies are driven by their insights in global economies and bond markets. They also emphasize sustainable investing, incorporating sustainability into their investment approach. The firm closely monitors global economic conditions and policy decisions, especially those of the US Federal Reserve, providing investors with insights on expected interest rate changes and their potential effects. They are also looking at the current high levels of equity valuations while fixed-income securities continues to provides attractive returns and diversification possibilities. They emphasize that volatility and surprises may characterize the investment landscape, and provide suggestions to navigate markets, while their investment ideas are focused on maintaining investor resilience and diversification across equity, bond, credit, and commodity sectors.
PINC (Paulig Group venture capital)
PINC, or Paulig Group venture capital, is not explicitly described on the crawled pages. However, based on Paulig Group's overall business, we can infer some aspects. Paulig Group is a significant player in the food and beverage industry, with a focus on Tex Mex, coffee, snacks, and industrial food solutions. Therefore, PINC likely focuses on investing in companies that align with Paulig's strategic goals, particularly in areas related to sustainable food systems, food technology, novel ingredients, and innovative food concepts. Their investments would likely target businesses that can contribute to Paulig's existing product portfolio, expand its market reach, or provide access to new technologies and consumer trends. Paulig's strategy for 2024-2026 emphasizes profitable, sustainable growth with a consumer-centric approach. The three growth platforms—Enjoyable Shared Moments, Taste Exploration, and Re-Imagined Snacking—likely influence PINC's investment decisions. Companies that can deliver on these platforms, offering delicious and convenient food experiences while prioritizing sustainability, would be prime candidates for investment. This could include businesses that develop innovative packaging solutions, reduce food waste, promote responsible sourcing, or create plant-based alternatives. Given Paulig's strong presence in the Nordic countries and the Baltics, PINC is likely to have a strong geographic focus on these regions, potentially extending to other European countries where Paulig has a significant market presence. The firm's investment strategy likely incorporates Paulig's values: Stay Curious, Strive for Excellence, and Grow Together. This suggests that PINC seeks out companies with innovative ideas, a commitment to quality, and a collaborative approach to business.
PMK-Group
PMK-Group, operating through PMK Ventures, focuses on fueling innovation in the Biotech and MedTech sectors. They provide strategic capital and expertise to early-stage companies worldwide, empowering them to advance healthcare solutions. Their mission is to guide groundbreaking ideas from concept to market by providing capital, service, mentorship, and networks to navigate the complex clinical R&D process. The firm recognizes the challenges in bringing life-saving innovations to market, including high costs, long timelines, and regulatory hurdles. They aim to de-risk projects by providing tailored funding, clinical R&D guidance, and access to a global network. This includes helping portfolio companies navigate clinical trials, access regulatory and scientific expertise, and make strategic hires and exits. PMK-Ventures targets early-stage Biotech & MedTech companies committed to long-term value creation, not just quick wins. They are based in Singapore with a global outlook. The firm is backed by experts in clinical development, regulation, and commercialization. They invest strategically with a company's roadmap in mind. PMK-Group aims to be more than just a source of capital; they provide ongoing professional support and de-risking, making them a unique partner in the healthcare innovation space.